FIGURE 3.

Data from cohort study (N=690) demonstrated that the 31-GEP test further informs risk analysis obtained by the American Joint Committee on Cancer (AJCC) staging protocol in patients with melanoma

MSS: melanoma-specific survival; NCCN: National Comprehensive Cancer Network

Reproduced with permission. Gastman BR, Gerami P, Kurley SJ, et al. Identification of patients at risk of metastasis using a prognostic 31-gene expression profile in subpopulations of melanoma patients with favorable outcomes by standard criteria. J Am Acad Dermatol. 2019;80(1):149–157.